Nephros, Inc.
NEPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $15,472 | $35,936 | $11,945 | $59,105 |
| - Cash | $3,760 | $4,307 | $3,634 | $6,973 |
| + Debt | $1,411 | $1,836 | $1,093 | $1,000 |
| Enterprise Value | $13,123 | $33,465 | $9,404 | $53,132 |
| Revenue | $14,162 | $14,238 | $9,975 | $10,217 |
| % Growth | -0.5% | 42.7% | -2.4% | – |
| Gross Profit | $8,723 | $8,405 | $4,731 | $5,633 |
| % Margin | 61.6% | 59% | 47.4% | 55.1% |
| EBITDA | $227 | -$1,359 | -$3,686 | -$2,491 |
| % Margin | 1.6% | -9.5% | -37% | -24.4% |
| Net Income | $74 | -$1,575 | -$7,382 | -$4,107 |
| % Margin | 0.5% | -11.1% | -74% | -40.2% |
| EPS Diluted | 0.007 | -0.15 | -0.72 | -0.41 |
| % Growth | 104.7% | 79.2% | -75.6% | – |
| Operating Cash Flow | -$492 | $827 | -$3,234 | -$1,417 |
| Capital Expenditures | -$55 | -$75 | -$137 | -$36 |
| Free Cash Flow | -$547 | $752 | -$3,371 | -$1,453 |